Sanofi — Director's Dealing 2013

Nov 7, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GLYCOMIMETICS INC (GLYC)
CIK: 0001253689
Period of Report: 2013-11-06

Reporting Person: Sanofi (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Preferred Stock	1193625	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Preferred Stock	$0		Common Stock (1193625)		Indirect

Footnotes

F1: One-to-One Conversion upon completion of Initial Public Offering